Escolar Documentos
Profissional Documentos
Cultura Documentos
By
K.S.RAJESH
11HF1SO316 C M COLLEGE OF PHARMACY Under the guidance of Mr. PAVAN PHARMACEUTICS REDDY KUMAR Dept OF
Dept OF PHARMACEUTICS
The three essential components, are: 1. The Ion Source : A small sample of compound is ionized, usually to cations by loss of an electron. 2. The Mass Analyzer :The ions are sorted and separated according to their mass and charge. 3. The Detector: The separated ions are then detected and tallied, and the results are displayed on a chart.
Dept OF PHARMACEUTICS
ADVANTAGES
Dept OF PHARMACEUTICS
Butorphanol N -CH2OH
Dept OF PHARMACEUTICS
Dept OF PHARMACEUTICS
Materials present at concentration less than one part per million can be easily detected. It is extremely sensitive and small quantity of sample is sufficient. It is capable of high precision. Proteins can now be sequenced by MS.
Dept OF PHARMACEUTICS
BASIC CONSIDERATIONS
SAMPLE:
Must have an obtainable vapour pressure of at least 10-7 mm Hg. IONS: Ions are produced from sample molecules by bombardment of electrons. Electrons must possess sufficient energy of 50-100eV. POSITIVE IONS: Positive ions are abundant than negative ions by a factor of 102-104.
Dept OF PHARMACEUTICS
INSTRUMENTATION
Dept OF PHARMACEUTICS
PRINCIPLE
Ions kinetic Energy as a function of accelerating voltage (V) and charge (e).
F=HeV
Dept OF PHARMACEUTICS
10
WORKING
Dept OF PHARMACEUTICS
11
Mass Spectrum
Mass spectrum: A plot of the relative abundance of ions versus their massto-charge ratio. Base peak: The most abundant (highest intensity) peak. Molecular ion peak: The peak formed at the highest mass number.
Dept OF PHARMACEUTICS
12
100%
43
50% 71 114
molecular ion
m/e
MS of METHANE
Molecular ion base peak fragments 1 15 16
Dept OF PHARMACEUTICS
14
Sample Introduction
Gas source: sample volatized and purified (by GC) and injected into mass spectrometry. Liquid source: handled similar to gases. Solid source: For metals and semi conductors spark source is used. Organic solids are handled by means of a probe.
Dept OF PHARMACEUTICS 15
ION SOURCE
The ionizing electrons are liberated by thermionic emission from heated tungsten or rhenium filament. TYPES OF ION SOURCE: Electron impact ionization Electron spray ionization Matrix assisted laser desorption ionization Spark ionization Surface ionization
Dept OF PHARMACEUTICS 16
ELECTRON IMPACT IONIZATION: In the ionization chamber, the sample is bombarded with a beam of high-energy electrons.
Dept OF PHARMACEUTICS
17
Dept OF PHARMACEUTICS
18
Dept OF PHARMACEUTICS
19
Partial vacuum
N2
+ + + + ++ ++ + + ++ ++ + + ++ + ++ + ++ + ++ + ++ + ++ + ++
MH+
+ +
+
+
+ + +
+ +
MH2+ MH3+
Charged droplets
Dept OF PHARMACEUTICS
20
Sample
+ _
Ionizer
Mass Analyzer
Detector
Dept OF PHARMACEUTICS
21
Sample is mixed with a UV absorbent matrix (sinapinic acid for proteins, 4hydroxycinnaminic acid for peptides) Sample is ionized by bombarding sample with laser light
337 nm UV laser
Dept OF PHARMACEUTICS
22
MALDI
Sample plate Laser
1. Sample is mixed with
MH+
2. Laser flash ionizes matrix molecules. 3. Sample molecules (M) are ionized by proton transfer: XH+ + M MH+ + X.
Grid (0 V)
+/- 20 kV
Dept OF PHARMACEUTICS
23
6.
7.
Molecular ion Fragment ion Meta Stable ion Isotopic ion Multiple charge ion Negatively charged ion Rearrangement ion
Dept OF PHARMACEUTICS 24
Molecular Ions:
Intensity of molecular ion peak in mass spectrometry depends on molecular ion stability. Molecular ions are stable in electron containing compounds. For the formation of molecular ions 10-5-10-7 mm Hg pressure and 70eV energy is required. Stability order: aromatic conjugated acyclic unbranched branched alcohols
Dept OF PHARMACEUTICS
25
Fragmentation of a molecular ion, M, produces a radical and a cation. Only the cation is detected by MS.
A + B+ Radical Cation A+ + B Cation Radical
Dept OF PHARMACEUTICS 26
A-B
Fragment Ions:
Homolytic Cleavage
Molecule(M)
Heterolytic cleavage
In homolytic cleavage a pair of electrons move independent of each other In heterolytic cleavage a pair of electrons move in same direction
Dept OF PHARMACEUTICS 27
Homolytic cleavage
CH3CH2 Cl CH3CH2Cl
CH2-CH Cl
CH3CH2+ + Cl.
H
Heterolytic cleavage
Dept OF PHARMACEUTICS 28
Meta stable
The position of meta stable ion peak can be obtained by using the formula m mass of daughter ion M mass of molecular ion
Dept OF PHARMACEUTICS 29
Isotopic Ions:
When isotopic ions differ by only one mass unit , the peak obtained is m+1 peak. Other peaks obtained in mass spectrometry is m+2 peak m+3 peak. Carbon, for example, in nature is 98.90% 12C and 1.10% 13C. There are 1.11 atoms of carbon-13 in nature for every 100 atoms of carbon-12.
Dept OF PHARMACEUTICS
30
M+2 Peaks
The most common elements giving rise to significant M + 2 peaks are chlorine and bromine.
Chlorine in nature is 75.77% 35Cl and 24.23% 37Cl. A ratio of M to M + 2 of approximately 3:1
Dept OF PHARMACEUTICS
31
M+2 Peaks
Bromine in nature is 50.7% 79Br and 49.3% 81Br. A ratio of M to M + 2 of approximately 1:1 indicates the presence of a single bromine atom in a compound
Dept OF PHARMACEUTICS
32
Isotopic Abundance
81Br
Dept OF PHARMACEUTICS
33
Multiple Charge Ions: In aromatic compounds the molecular ion formed is highly stable.
.+ e M
molecular Ion charged
M+2
doubly charged
M+3
triply
M+2
M+3
Dept OF PHARMACEUTICS
34
M-
They are formed in rare case. Do not have any importance in mass spectrometry.
Dept OF PHARMACEUTICS
35
Rearrangement ions
Retro
Diels-alder: +
.
CH2
+.
+
CH2 CH2
CH2
McLafferty:
H Z H Z CH2 CH2 Z R Z R
Dept OF PHARMACEUTICS
36
Dept OF PHARMACEUTICS
37
Dept OF PHARMACEUTICS
38
Quadrupole Analyzer
Four parallel rods or poles through which the ions being separated are passed. Poles have a fixed DC and alternating RF voltages applied to them.
Depending on the produced electric field, only ions of a particular m/e will be focused on the detector, all the other ions will be deflected
Dept OF PHARMACEUTICS
39
Quadrupole Analyzer
Dept OF PHARMACEUTICS
40
Time-of-Flight (TOF)Analyzer
This type of analyzer measures the time for ions to reach the detector. Small ions reach the detector before large ones. There are two types of TOF analyzers MALDI-TOF Analyzer Q-TOF Analyzer
Dept OF PHARMACEUTICS
41
MALDI-TOF ANALYZER
peptide mixture embedded in light absorbing chemicals (matrix) pulsed UV or IR laser (3-4 ns) detector
+ + + + +
vacuum
+
+
Vacc
Dept OF PHARMACEUTICS
42
MALDI-TOF ANALYZER
Linear Tim e O f Flight tube
ion source
detector
tim e of flight
detector reflector
Dept OF PHARMACEUTICS
tim e of flight
43
Q-TOF ANALYZER
NANO SPRAY TIP MCP DETECTOR
PUSHER
HEXAPOLE
TOF
REFLECTRON
QUADRUPOLE
SKIMMER ION SOURCE
HEXAPOLE
Dept OF PHARMACEUTICS
44
Ion traps are ion trapping devices that make use of a three-dimensional quadrupole field to trap and massanalyze ions
Dept OF PHARMACEUTICS
45
Dept OF PHARMACEUTICS
46
DETECTORS
Early detectors used photographic methods, this is called Mass Spectrograph. Todays detectors produce electronic signals by secondary electronic emission when struck by an ion. Types of detectors used are: Faraday cup Electron multiplier Photographic detection
Dept OF PHARMACEUTICS 47
Faraday collector
Electron multiplier
Dept OF PHARMACEUTICS
48
FRAGMENTATION RULES
1. 2. 3.
Intensity of M.+ is Larger for linear chain than for branched compound Intensity of M.+ decrease with Increasing M.W. Cleavage is favored at branching.
R R CH R
Dept OF PHARMACEUTICS
49
Dept OF PHARMACEUTICS
50
Branched alkanes
H3C H3C H3C H3C H3C CH3 CH3
MW=170
Dept OF PHARMACEUTICS
51
FRAGMENTATION RULES
4. Aromatic Rings, Double bond, Cyclic structures stabilize M.+
Dept OF PHARMACEUTICS
52
FRAGMENTATION RULES
5. a) Saturated Rings lose a Alkyl Chain (case of branching)
R
+.
-R
+
.
Dept OF PHARMACEUTICS
53
FRAGMENTATION RULES
6. Alkyl substituted aromatic Compounds Cleave in b Resonance Stabilized Tropylium ion
R C CH CH2
-R
.
CH
CH2
+
Dept OF PHARMACEUTICS 54
FRAGMENTATION RULES
7. C-C Next to Heteroatom cleave leaving the charge on the Heteroatom
- [RCH2]
R
+
CH2
CH2
H2C
H2C
Dept OF PHARMACEUTICS
55
FRAGMENTATION RULES
8. Cleavage of small neutral molecules (CO2, CO, olefins, H2O .) Result often from McLafferty rearrangement. McLafferty Rearrangement: Intra molecular migration of hydrogen from e- rich centre to e- deficit centre followed by cleavage at position resulting in elimination of an alkene.
Dept OF PHARMACEUTICS 56
McLAFFERTY REARRANGEMENT
x
O C Y CH2
CH2 CH2 Y
O C CH2
H CH2 CH2
- CH2=CH2
Y H, R, OH, NR2
O C Y
x
CH2
FRAGMENTATION RULES
Nitrogen Rule: If a compound has zero or an even number of nitrogen atoms, its molecular ion will have an even m/z value. an odd number of nitrogen atoms, its molecular ion will have an odd m/z value. Ring Rule: The number of unsaturated site, R is equal to the number of double bonds and/or rings in the molecule. Ring rule for molecule CaHbNcOd .
Dept OF PHARMACEUTICS 58
Dept OF PHARMACEUTICS 59
Dept OF PHARMACEUTICS
60
Dept OF PHARMACEUTICS
61
ALKENES
Alkenes characteristically show a strong molecular ion peak. Alkenes prefer to fragment at position to double bond. o cleave to form resonance-stabilized allylic cations
CH2 CH3
Dept OF PHARMACEUTICS
62
ALKENES
Dept OF PHARMACEUTICS
63
ALKYNES
Alkynes typically show a strong molecular ion peak. cleave readily to form the resonance stabilized propargyl cation or substituted propargyl cations.
HC C=CH2
Dept OF PHARMACEUTICS
64
ALKYNES
Dept OF PHARMACEUTICS
65
Alcohols
One of the most common fragmentation patterns of alcohols is loss of H2O to give a peak which corresponds to M-18. Another common pattern is loss of an alkyl group from the carbon bearing the OH to give a resonance-stabilized R' oxonium ion and an alkyl radical. + + +
R + A radical
Alcohols
Dept OF PHARMACEUTICS
67
CH3
McLafferty re arrangement
H +
m/z 58
Dept OF PHARMACEUTICS 68
Dept OF PHARMACEUTICS
69
Carboxylic Acids
Characteristic fragmentation patterns are a-cleavage to give the ion [CO2H]+ with m/z 45. McLaffertya-cleavage rearrangement O
OH Mole cular ion m/z 88
H O OH Mole cular ion m/z 88
Dept OF PHARMACEUTICS
O= C-O- H m/z 45
McLafferty re arrangement +
O OH
m/z 60
70
Carboxylic Acids
Dept OF PHARMACEUTICS
71
Esters
O +
OCH 3
+ m/z 71 +
O OCH 3
McLafferty re arrangement
H +
Aromatic Hydrocarbons
- H
H
+
H H
Dept OF PHARMACEUTICS
73
Amines
Dept OF PHARMACEUTICS
74
AROMATIC ETHER
O
x
O
R
- R
-CO
C5H5
m/z 93
- CH2=CH2
H Rearrangement
H H
m/z 94
O H
x
Dept OF PHARMACEUTICS
75
Aliphatic Ether
Resolution
Resolution: A measure of how well a mass spectrometer separates ions of different mass. Low resolution: Refers to instruments capable of separating only ions that differ in nominal mass; that is ions that differ by at least 1 or more atomic mass units (amu). High resolution: Refers to instruments capable of separating ions that differ in mass by as little as 0.0001 amu.
Dept OF PHARMACEUTICS 77
R=m/m m is the mass of the first peak m is the mass difference between two adjacent peaks that are just resolved
Dept OF PHARMACEUTICS
78
Monoisotopic mass
Monoisotopic mass corresponds to lowest mass peak
When the isotopes are clearly resolved the monoisotopic mass is used as it is the most accurate measurement.
Dept OF PHARMACEUTICS
79
Average mass
Average mass corresponds to the centroid of the unresolved peak cluster
When the isotopes are not resolved, the centroid of the envelope corresponds to the weighted average of all the the isotope peaks in the cluster, which is the same as the Dept OF PHARMACEUTICS 80 average or chemical mass.
Different Types of MS
GC-MS - Gas Chromatography MS separates volatile compounds in gas column and IDs by mass LC-MS - Liquid Chromatography MS separates delicate compounds in HPLC column and IDs by mass MS-MS - Tandem Mass Spectrometry separates compound fragments by magnetic field and IDs by mass LC/LC-MS/MS-Tandem LC and Tandem MS Separates by HPLC, IDs by mass and AA sequence Dept OF PHARMACEUTICS 81
LC-MS..
Study protein complexes without gel electrophoresis
Peptides all bind to cation exchange column Successive elution with increasing salt gradients separates peptides by are Peptides charge separated by hydrophobicit y on reverse phase column
Dept OF PHARMACEUTICS
82
LC-MS...
Dept OF PHARMACEUTICS
83
GC-MS
A mixture of compounds is separated by gas chromatography, then identified by mass spectrometry.
Dept OF PHARMACEUTICS
84
separation and identification of compounds in complex mixtures - Uses two or more mass analyzers/filters separated by a collision cell filled with Argon or Xenon - induce fragmentation and mass analyze the fragment ions.
Mixture of ions Single ion
MS-1 MS-2
Dept OF PHARMACEUTICS 85
Fragments
Ion source
Pharmaceutical analysis Analysis of mixture Component analysis Gas analysis Isotope abundance measurement Thermodynamic studies Ionization potential measurement
Dept OF PHARMACEUTICS
86
Dept OF PHARMACEUTICS
87
Protein Identification
Dept OF PHARMACEUTICS
88
Used to identify protein spots on gels or protein peaks from an HPLC run Depends of the fact that if a peptide is cut up or fragmented, the resulting fragments (and resulting masses) are enough to identify the protein
Dept OF PHARMACEUTICS
90
PROBLEM
Bank President
Who robbed the bank?
Dept OF PHARMACEUTICS
91
1. Interview biologist who isolated the protein 2. Cleave protein to obtain peptide mixture
enzyme
Dept OF PHARMACEUTICS
92
DATABASE SEARCH
Police Officer
Height: 57
Weight: 160 lbs Gender: male Age: 35-40
Mass Spectrometrist
Approx. molecular weight: 30,000
Origin: bovine liver Peptide mass list from MS analysis: 975.4832, 1112.5368, 632.3147, 803.4134, 764.3892
Fingerprints
search
search
PEPTIDE MASS DATABASE OF KNOWN PROTEINS
Dept OF PHARMACEUTICS 93
DATABASE SEARCH RESULTS Police Officer Identifies the robber Antony J. Felon Mass Spectrometrist
Identifies the protein
bovine carbonic anhydrase
Dept OF PHARMACEUTICS
94
Chemically reactive group: forms a covalent bond to the protein or peptide Isotope-labeled linker: heavy or light, depending on which isotope is used Affinity tag: enables the protein or peptide bearing an ICAT to be isolated by affinity chromatography in a single step
Label protein samples with heavy and light reagent Reagent contains affinity tag and heavy or light isotopes
Dept OF PHARMACEUTICS
95
Reactive group: Indoacetamide-reactive group will bind to Cysteine Linker: Heavy version will have deuterium at * Light version will have hydrogen's at * H
* *
H N S O
O O
O
*
N I O
96
Dept OF PHARMACEUTICS
Dept OF PHARMACEUTICS
97
Light
100 MIX
100
Heavy
200
400 m/z
600
98
Dept OF PHARMACEUTICS
Dept OF PHARMACEUTICS
A modern radiograph of a hand
99
SOURCE OF X-RAY
Target
X-rays
Beam of electrons
Dept OF PHARMACEUTICS
100
Target Metal Mo
Of Ka radiation () 0.71
Cu
Co Fe Cr
1.54
1.79 1.94 2.29
Dept OF PHARMACEUTICS
101
TYPES OF X-RAY
X-rays are produced when high energy electrons bombard with target molecule. Vacuum
Energy levels
E L3 E L2 E L1
L3
L2
L1
K
EK Nucleus
Characteristic x-rays
Dept OF PHARMACEUTICS
102
Dept OF PHARMACEUTICS
103
Intensity
White radiation
Kb
0.2
0.6
1.0
1.4
Dept OF PHARMACEUTICS
Wavelength ()
104
X RAY DIFFRACTION
The atoms or ions are arranged in the regular places in a crystal. When x-rays are incident on crystal they are diffracted from the atoms or ions, they may have constructive interference or a destructive interference.
Dept OF PHARMACEUTICS
105
BRAGGS EQUATION
Braggs Law:
2dsin = n
= X-ray wavelength
Dept OF PHARMACEUTICS
107
APPLICATIONS
Phase
Composition of a Sample: determine the relative amounts of phases in a mixture by referencing the relative peak intensities. Unit cell lattice parameters and Bravais lattice symmetry. Crystal Structure Texture/Orientation
Dept OF PHARMACEUTICS
108
XRD can be used to investigate the crystal environment of particular atoms Ta displaying cubic
symmetry in the mineral microlite.
Dept OF PHARMACEUTICS
REFERENCES
B.K.SHARMA Pg:
S-844 to S-922 A.H BECKETT & J.B.STENLAKE Pg: 78-81, 474, 477. Gurdeep R Chatwal Pg:2.272-2.302 Mass spectrometry instrumentation, interpretation and application by Rolf Ekman, Jerzy silberring.
Chem-805
Dept OF PHARMACEUTICS
110
Dept OF PHARMACEUTICS
111